View Clinical Trial (Medical Research Study)

Bipolar Depression Research Study - NCT00376220-21287(Clinical Trial 149615)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Baltimore
State:  
MD
Zip Code: 21287
Conditions: Bipolar Disorder
Purpose: The Johns Hopkins Department of Psychiatry is conducting a research study to examine the effectiveness of riluzole in treating the depressed phase of bipolar disorder. This outpatient treatment study of medication or placebo will last 9-12 weeks. The study includes medical and psychiatric evaluations as well as time-limited medication treatment at no cost, and you will be compensated for your participation.
Study summary: The study will last 8 to 12 weeks and requires weekly visits. Participants will come to Johns Hopkins for a screening visit during which they will talk with a psychiatrist, answer questions about their mood and symptoms, have their blood drawn and have a brief physical exam. If they meet criteria for the study, any antidepressant medication that they are taking will be tapered and stopped before beginning study medications. Participation in the study includes free study medication, labs, and testing plus reimbursement for transportation. Participants will also be paid and after the study referred back to their treating psychiatrist with treatment recommendations.
Criteria: Inclusion Criteria: - Ages 18-75 - Diagnosed with Bipolar I or II disorder and currently depressed - Tried at least one antidepressant during the current episode of depression - Currently taking either lithium, depakote, or tegretol - Currently in outpatient treatment with a psychiatrist Exclusion Criteria: - Current psychotic symptoms - Women who are pregnant or nursing - Any serious, uncontrolled medical illness - History of liver problems - Current or past blood diseases - Current drug or alcohol abuse - Currently receiving Electroconvulsive Shock Therapy (ECT) - Judged to be at serious suicidal risk
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: May 21, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.